Huntington’s disease (HD) is an inherited disorder in which the nerve cells in parts of the brain gradually break down and ...

For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...

The specific labeling of RNA in living cells poses many challenges. In a new article published in the journal Nature Chemical ...

Diabetes has long been lumped into two categories—type 1, which often appears in childhood, or type 2, which is associated ...

Principal Financial Group Inc. increased its holdings in shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) by 230.0% in the third quarter, according to the company in its most recent ...

The foot is a complex structure made up of 28 bones, 33 joints, 19 muscles, over 100 tendons and ligaments, and more than 200,000 different nerve endings. These work together to allow you to walk, run ...

an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs ...

Structure Therapeutics Inc. has selected a lead oral small-molecule amylin receptor agonist, ACCG-2671, for the treatment of obesity. ACCG-2671 is a dual amylin and calcitonin receptor agonist (DACRA) ...

Laboratory testing revealed his glucagon was 536pg/ml (normal ... This patient had stomatitis with congestion and edema, but bronchoscopy showed that the tissue structure of the airway below the ...

Researchers at the University of Plymouth are leading an innovative initiative to advance the study of meningiomas in NF2-related schwannomatosis (NF2-SWN). Meningiomas, often linked to the loss ...

When doctors and nurses pass patient information from one shift to another -; an exchange known as a "handoff" -; the specific words they use behind closed doors matter more than they might realize.